You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Bacteriologic outcomes at the post-therapy/test of cure evaluation for the bacteriologically evaluable and bacteriologic modified intent to treat (bmITT) populations.

From: Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study

  Bacteriologically Evaluable Population bmITT Population
Assessment n (%) 95% CI* n (%) 95% CI*
n 149   255  
Satisfactory 137 (91.9) 87.5; 96.3 215 (84.3) 79.8; 88.8
Unsatisfactory 12 (8.1)   40 (15.7)  
Indeterminate -   16 (6.3)  
  1. *Two-sided 95% confidence interval (CI).
  2. Includes eradication, presumed eradication, and colonization.
  3. Includes reinfection, superinfection, recurrence, presumed persistence, and persistence.